Results 1 to 10 of about 47,786 (197)

Mitomycin C in pterygium treatment [PDF]

open access: yesInternational Journal of Ophthalmology, 2016
Pterygium is a benign lesion usually growing from the nasal side of the conjunctiva onto the cornea. Most cases of pterygium does not cause problem or requires specific treatment.
Thiago Gonçalves dos Santos Martins   +4 more
doaj   +3 more sources

Clinical outcomes of PRESERFLO Microshunt procedure with mitomycin C alone versus with mitomycin C and bevacizumab [PDF]

open access: yesTherapeutic Advances in Ophthalmology
Background: The PRESERFLO ® Microshunt procedure offers a safe and effective alternative to trabeculectomy procedure. The adjuvant use of anti-vascular endothelial growth factor (VEGF) with trabeculectomy has been well studied, yet little is known on the
Inas Gadelkarim   +3 more
doaj   +2 more sources

Analysis of HepG2 cell response to a wide concentration range of mitomycin C using a multichannel quartz crystal microbalance system with a microscope

open access: yesHeliyon, 2023
The morphological response of HepG2 cells to mitomycin C was analyzed using a multichannel quartz crystal microbalance system equipped with a home-built movable microscope that enables the simultaneous acquisition of cell images and measurements of eight-
Hiroshi Muramatsu   +3 more
doaj   +1 more source

EFFICACY OF SEQUENTIAL BCG AND MITOMYCIN VERSUS MITOMYCIN ALONE FOR TREATMENT OF SUPERFICIAL BLADDER CANCER [PDF]

open access: yesBasrah Journal of Surgery, 2012
A study to compare the efficacy and local toxicity of combining anticancer drugs immunotherapy and chemotherapy (Sequential BCG and mitomycin c) versus mitomycin alone in the treatment of superficial bladder cancer after complete transurethral resection.
Hazim R Akal
doaj   +1 more source

Two routes of administration of mitomycin C in a trabeculectomy

open access: yesIndian Journal of Ophthalmology, 2023
Background: The introduction of mitomycin C (MMC) as an adjunct to trabeculectomy was a major advance in the ability to improve the Intra ocular pressure lowering efficiency of the procedure.
Manju Pillai   +3 more
doaj   +1 more source

Efficacy of mitomycin C in modified transcanalicular diode laser dacryocystorhinostomy [PDF]

open access: yesRevista Brasileira de Oftalmologia, 2022
Objective: To evaluate the efficacy of mitomycin C in anatomical and functional success after modified transcanalicular diode laser dacryocystorhinostomy. Methods: A prospective, double-blinded, randomized placebo-controlled study compared the effect of
Eduardo Damous Feijó   +5 more
doaj   +1 more source

The Possible Role of the Long Non-coding RNA NORAD in Mitomycin C-Related Chemoresistance

open access: yesNamık Kemal Tıp Dergisi, 2022
Aim:Non-coding ribonucleic acid (RNA) activated by deoxyribonucleic acid (DNA) damage (NORAD) is a long non-coding RNA activated during DNA damage response.
İbrahim BOZGEYİK
doaj   +1 more source

Mitomycin C in ophthalmology

open access: yesJournal of the Scientific Society, 2012
Introduction to the use of Mitomycin C in ophthalmology was a significant development in the 1960s. Its use and application in ophthalmology has been increasing in recent years, because of its modulatory effects on wound healing.
Rekha Mudhol, N D Zingade, R S Mudhol
doaj   +1 more source

Mitomycin C induces apoptosis in human epidural scar fibroblasts after surgical decompression for spinal cord injury

open access: yesNeural Regeneration Research, 2017
Numerous studies have shown that topical application of mitomycin C after surgical decompression effectively reduces scar adhesion. However, the underlying mechanisms remain unclear.
Tao Sui   +5 more
doaj   +1 more source

Intraoperative injection versus sponge-applied mitomycin C during trabeculectomy: One-year study

open access: yesIndian Journal of Ophthalmology, 2020
Purpose: To determine the safety and efficacy of mitomycin C (MMC) injection versus sponge during trabeculectomy. Methods: It is a prospective analysis of patients who underwent trabeculectomy with MMC and followed up for 1 year, divided into two groups,
Devendra Maheshwari   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy